Smith David Ross
SEC CIK 1650274 · EDGAR
BoughtSold
Most active insiders at FTRE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Thakral Anshul | CEO, Dir | — | $3.94M |
| 2 | Morais Mark A. | COO | — | $370.7K |
| 3 | SANDERS MACHELLE | Dir | — | $174.7K |
| 4 | Mcconnell Jill G. | CFO | — | $150.1K |
| 5 | Parks Robert | CAO | — | $44.4K |
| 6 | Russell Carrie Elizabeth | Interim CAO | — | $4,145 |
| 7 | Ray Amrit | Dir | — | — |
| 8 | Smith David Ross | Dir | — | — |
| 9 | Russell Erin L | Dir | — | — |
| 10 | Pesicka Edward A | Dir | — | — |
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-27 07:52 | 2026-07-20 | FTRE | Fortrea Holdings Inc. | Smith David Ross | Dir | M - OptEx | $0.00 | +6,598 | 36.7K | +22% | $0 | |
| D | 2026-06-12 16:17 | 2026-06-10 | FTRE | Fortrea Holdings Inc. | Smith David Ross | Dir | M - OptEx | $0.00 | +38.8K | 48.4K | +407% | $0 |
| D | 2026-06-12 16:17 | 2026-06-10 | FTRE | Fortrea Holdings Inc. | Smith David Ross | Dir | F - Tax | $16.34 | -18.2K | 30.1K | -38% | -$298.1K |
| D | 2025-05-16 | 2025-05-14 | FTRE | Fortrea Holdings Inc. | Smith David Ross | Dir | M - OptEx | $0.00 | +7,282 | 11.7K | +164% | $0 |
| D | 2025-05-16 | 2025-05-14 | FTRE | Fortrea Holdings Inc. | Smith David Ross | Dir | F - Tax | $4.78 | -2,185 | 9,544 | -19% | -$10.4K |
| D | 2024-07-19 | 2024-07-18 | FTRE | Fortrea Holdings Inc. | Smith David Ross | Dir | F - Tax | $25.85 | -1,907 | 4,447 | -30% | -$49.3K |
| D | 2024-07-19 | 2024-07-18 | FTRE | Fortrea Holdings Inc. | Smith David Ross | Dir | M - OptEx | $0.00 | +6,354 | 6,354 | New | $0 |
| DM | 2022-03-04 | 2022-03-03 | CRL | Charles River Laboratories | Smith David Ross | CFO, Corp. Executive VP | M - OptEx | $136.60 | +8,965 | 29.7K | +43% | +$1.22M |
| DM | 2022-03-04 | 2022-03-03 | CRL | Charles River Laboratories | Smith David Ross | CFO, Corp. Executive VP | S - Sale+OE | $282.53 | -8,965 | 27.1K | -25% | -$2.53M |
| 2022-03-02 | 2022-02-28 | CRL | Charles River Laboratories | Smith David Ross | CFO, Corp. Executive VP | A - Grant | $0.00 | +5,152 | 25.8K | +25% | $0 | |
| M | 2022-02-24 | 2022-02-22+ | CRL | Charles River Laboratories | Smith David Ross | CFO, Corp. Executive VP | F - Tax | $291.50 | -715 | 20.7K | -3% | -$208.4K |
| 2022-02-01 | 2022-01-28 | CRL | Charles River Laboratories | Smith David Ross | CFO, Corp. Executive VP | F - Tax | $312.24 | -5,364 | 21.4K | -20% | -$1.67M | |
| 2022-02-01 | 2022-01-28 | CRL | Charles River Laboratories | Smith David Ross | CFO, Corp. Executive VP | A - Grant | $0.00 | +12.3K | 26.7K | +85% | $0 | |
| M | 2021-08-10 | 2021-08-09 | CRL | Charles River Laboratories | Smith David Ross | CFO, Corp. Executive VP | S - Sale | $407.40 | -1,750 | 14.4K | -11% | -$713.0K |
Purchase Sale Sale after option exercise All abbreviations